Current Controversies and Challenges in Brugada Syndrome
More than three decades since its initial description in 1993, Brugada syndrome remains engulfed in controversy. This review aims to shed light on the main challenges surrounding the diagnostic pathway and criteria, risk stratification of asymptomatic patients, pharmacological and interventional ris...
Guardado en:
Autores principales: | Afik D Snir, Hariharan Raju |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/924ef43354f64c3f9518a0efa09e1a0e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Insights for Stratification of Risk in Brugada Syndrome
por: Daniel García Iglesias, et al.
Publicado: (2019) -
Brugada Syndrome: Progress in Diagnosis and Management
por: Carlo Pappone, et al.
Publicado: (2019) -
Brugada Syndrome: Progress in Genetics, Risk Stratification and Management
por: Jorge Romero, et al.
Publicado: (2019) -
Featuring: Josep Brugada
por: Josep Brugada
Publicado: (2019) -
Type‐I Paradox of Brugada Syndrome
por: Sami Viskin, et al.
Publicado: (2018)